ALG13
-
Official Full Name
asparagine-linked glycosylation 13 homolog (S. cerevisiae)
-
Overview
The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. -
Synonyms
ALG13; asparagine-linked glycosylation 13 homolog (S. cerevisiae); chromosome X open reading frame 45 , CXorf45, GLT28D1, glycosyltransferase 28 domain containing 1; UDP-N-acetylglucosamine transferase subunit ALG13 homolog; FLJ23018; MDS031; YGL047W; Glycosyltransferase 28 domain containing protein 1; UDP N acetylglucosamine transferase subunit ALG13 homolog; glycosyltransferase 28 domain containing 1; glycosyltransferase 28 domain-containing protein 1; hematopoietic stem/progenitor cells protein MDS031; CXorf45; GLT28D1;
- Recombinant Proteins
- Cell & Tissue Lysates
- Protein Pre-coupled Magnetic Beads
- Human
- Mouse
- Rat
- Zebrafish
- E.coli
- HEK293
- Mammalian Cell
- GST
- His
- His (Fc)
- Avi
- N/A
- No tag
- Involved Pathway
- Protein Function
- Interacting Protein
- ALG13 Related Articles
ALG13 involved in several pathways and played different roles in them. We selected most pathways ALG13 participated on our site, such as N-Glycan biosynthesis, Metabolic pathways, which may be useful for your reference. Also, other proteins which involved in the same pathway with ALG13 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
Pathway Name | Pathway Related Protein |
---|---|
N-Glycan biosynthesis | DAD1;STT3A;GANAB;MAN1B1;ALG10;ALG10B;MGAT4B;MGAT4C;ALG2 |
Metabolic pathways | HSD17B12B;ST3GAL2;EXTL2;UROD;B4GALT6;PKM;C1GALT1A;HPSE2;NADKA |
ALG13 has several biochemical functions, for example, N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity, cysteine-type peptidase activity, poly(A) RNA binding. Some of the functions are cooperated with other proteins, some of the functions could acted by ALG13 itself. We selected most functions ALG13 had, and list some proteins which have the same functions with ALG13. You can find most of the proteins on our site.
Function | Related Protein |
---|---|
N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity | |
cysteine-type peptidase activity | SENP8;CTSL.1;CTSL2;OTUD4;CTSL1;UFSP2;CASP8L1;CTSJ;BLMH |
poly(A) RNA binding | DDX5;RPS9;OASL;RBM12B1;CHCHD1;CNBP;RPL10A;NOP16;RBBP6 |
protein binding | SMR3B;NTM;FANCF;HTRA2;RABGAP1;HEMGN;GSTZ1;COPS3;JUND |
ALG13 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with ALG13 here. Most of them are supplied by our site. Hope this information will be useful for your research of ALG13.
ATN1; mscS2; RERE; q9wmx2-pro_0000037548; SAV1
- Q&As
- Reviews
Q&As (19)
Ask a questionThe protein encoded by the ALG13 gene catalyzes its receptor in an acylated manner, making it a substrate for glycosyltransferase, thereby transmitting its catalytic activity.
The mutations have been linked to neurological disorders such as idiopathic epilepsy and intellectual disability.
Appropriate genetic analysis methods, including single genotypic/association analysis and genome-linked DNA polymorphism analysis, can be used to assess the genetic risk of ALG13 gene variation and neurological diseases.
At present, there are not enough studies to prove that ALG13 mutations are directly related to diseases such as cardiovascular disease and metabolic syndrome.
ALG13 is a member of the UDP-glucose-glycosyltransferase family, which is mainly involved in protein glycosylation.
The ALG13 gene has not been linked to the evolutionary history of humans.
This mutations may affect neuronal development and nerve conduction processes, leading to a range of neurological diseases.
CRISPR/Cas9 gene editing technology can be used to construct ALG13 gene knockout or mutant cell lines, and its effects on cell growth and glycosylation process can be analyzed through comparative experiments.
No studies have directly linked ALG13 with AMPK and mTOR, and further research is needed.
The potential role of ALG13 in the early prediction and treatment of diabetes has not been studied, which requires further research.
In this study, we can use gene editing technology to construct ALG13 gene knockout or mutant cell lines, and then compare the differences in glucose metabolism and energy metabolism between them and wild-type cells.
There is currently no direct evidence of a correlation between ALG13 and metabolism and obesity.
At present, there is no conclusive evidence that ALG13 has a direct regulatory effect on glucose levels and energy metabolism, but genomic studies suggest that it may be involved in the mechanisms of glucose metabolism pathways.
ALG13 encodes an important glycosyltransferase, and its mutation can affect the glycosylation process of proteins, and thus affect the efficiency and quality of glycosylation.
Glycosylation is one of the important ways of protein modification, and the glycosylation of ALG13 can affect the folding, activity and stability of the protein, so as to affect the function of the protein.
The enzyme activity of ALG13 is controlled by various regulatory mechanisms. One is to interact with the sugar chain component glycosyl budding to regulate its activity and stability; The other is its own acylation modification, which affects the activity.
ALG13 is involved in metastasis as glycosylation and affects neuronal papillary process signaling, etc. Further studies are needed to understand its unique mechanism.
The relationship between ALG13 gene polymorphism and other genetic or environmental factors is limited and further research is needed.
The amount and pattern of ALG13 expression in different tissues are different, such as high expression in brain, lung and kidney.
Customer Reviews (3)
Write a reviewStrong antioxidant effect, can inhibit the formation of free radicals, reduce oxidation reaction.
The clinical detection method is mature.
Great performance in ELISA.
Ask a Question for All ALG13 Products
Required fields are marked with *
My Review for All ALG13 Products
Required fields are marked with *